These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26070757)

  • 1. Neurobehavioral Sequelae of Psychostimulant Abuse.
    Djamshidian A
    Int Rev Neurobiol; 2015; 120():161-77. PubMed ID: 26070757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate homeostasis and dopamine signaling: Implications for psychostimulant addiction behavior.
    Fischer KD; Knackstedt LA; Rosenberg PA
    Neurochem Int; 2021 Mar; 144():104896. PubMed ID: 33159978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding drug addiction: a neuropsychological perspective.
    Yücel M; Lubman DI; Solowij N; Brewer WJ
    Aust N Z J Psychiatry; 2007 Dec; 41(12):957-68. PubMed ID: 17999268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A neuropeptide-centric view of psychostimulant addiction.
    Boutrel B
    Br J Pharmacol; 2008 May; 154(2):343-57. PubMed ID: 18414383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transitionality in addiction: A "temporal continuum" hypotheses involving the aberrant motivation, the hedonic dysregulation, and the aberrant learning.
    Patrono E; Gasbarri A; Tomaz C; Nishijo H
    Med Hypotheses; 2016 Aug; 93():62-70. PubMed ID: 27372858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychostimulants: Basic and Clinical Pharmacology.
    McCreary AC; Müller CP; Filip M
    Int Rev Neurobiol; 2015; 120():41-83. PubMed ID: 26070753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of serotonin in drug use and addiction.
    Müller CP; Homberg JR
    Behav Brain Res; 2015 Jan; 277():146-92. PubMed ID: 24769172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulant medications: how to minimize their reinforcing effects?
    Volkow ND
    Am J Psychiatry; 2006 Mar; 163(3):359-61. PubMed ID: 16513852
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural plasticity of the brain to psychostimulant use.
    Nyberg F
    Neuropharmacology; 2014 Dec; 87():115-24. PubMed ID: 25018041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors.
    Müller CP; Carey RJ; Huston JP; De Souza Silva MA
    Prog Neurobiol; 2007 Feb; 81(3):133-78. PubMed ID: 17316955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arresting the Development of Addiction: The Role of
    Porter-Stransky KA; Weinshenker D
    J Pharmacol Exp Ther; 2017 Jun; 361(3):341-348. PubMed ID: 28302862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of impulsivity in psychostimulant- and stress-induced dopamine release: Review of human imaging studies.
    Bosker WM; Neuner I; Shah NJ
    Neurosci Biobehav Rev; 2017 Jul; 78():82-90. PubMed ID: 28438467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addiction and mental health.
    Krausz M
    Eur Addict Res; 1999 Jun; 5(2):53-4. PubMed ID: 10515702
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurologic Complications of Psychomotor Stimulant Abuse.
    Sanchez-Ramos J
    Int Rev Neurobiol; 2015; 120():131-60. PubMed ID: 26070756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic mice in the study of drug addiction and the effects of psychostimulant drugs.
    Sora I; Li B; Igari M; Hall FS; Ikeda K
    Ann N Y Acad Sci; 2010 Feb; 1187():218-46. PubMed ID: 20201856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro- and anti-addictive neurotrophic factors and cytokines in psychostimulant addiction: mini review.
    Yamada K; Nabeshima T
    Ann N Y Acad Sci; 2004 Oct; 1025():198-204. PubMed ID: 15542718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-the-counter stimulants: abuse and addiction.
    Tinsley JA; Watkins DD
    Mayo Clin Proc; 1998 Oct; 73(10):977-82. PubMed ID: 9787749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine transporters and psychostimulant addiction.
    Howell LL; Kimmel HL
    Biochem Pharmacol; 2008 Jan; 75(1):196-217. PubMed ID: 17825265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are "physiological" and "psychological" addiction really different? well, no! ... um, er, yes?
    Newlin DB
    Subst Use Misuse; 2008; 43(7):967-71. PubMed ID: 18570028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [DSM-5--what has changed in therapy for and research on substance-related and addictive disorders?].
    Baumgärtner G; Soyka M
    Fortschr Neurol Psychiatr; 2013 Nov; 81(11):648-54. PubMed ID: 24194058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.